| Literature DB >> 15649453 |
Kerstin Franke1, Thomas Harder, Leona Aerts, Kerstin Melchior, Sonja Fahrenkrog, Elke Rodekamp, Thomas Ziska, F André Van Assche, Joachim W Dudenhausen, Andreas Plagemann.
Abstract
Exposure to maternal diabetes in utero (GD) may 'program' for obesity. Orexigenic neuropeptides, like neuropeptide Y (NPY) and agouti-related peptide (AGRP), and anorexigenic neuropeptides, like proopiomelanocortin (POMC) and alpha-melanocyte-stimulating hormone (MSH), are decisively involved in body weight regulation. We investigated consequences of GD and its treatment by pancreatic islet transplantation in rats for development of neuropeptidergic neurons in the arcuate hypothalamic nucleus (ARC) in weanling offspring. In GD, islet transplantation on d15 of pregnancy led to normalized blood glucose. Sham-transplanted GD mothers (TSGD) remained hyperglycemic. Twenty-one-day-old TSGD offspring developed hypothalamic 'malorganization'. Despite of normal leptin and insulin levels in TSGD offspring, increased immunopositivity of NPY and AGRP appeared. TSGD offspring showed unchanged POMC, but decreased MSH-immunopositivity. In conclusion, untreated diabetes in pregnant rats leads to 'malprogramming' of hypothalamic neuropeptidergic neurons in offspring, probably contributing to later development of overweight. These acquired alterations are preventable by treatment of maternal GD.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15649453 DOI: 10.1016/j.brainres.2004.11.006
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252